A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
A Pilot Distress Screening and Referral Program to Detect Comorbid Psychosocial Distress in NYC Safety Net Hospitals Serving Diverse and Underserved Patients Diagnosed With Cancer
1 other identifier
interventional
50
1 country
2
Brief Summary
It is recommended that cancer centers screen patients for distress and refer them to mental health services when their distress levels reach a certain level. However, many cancer centers don't have distress screening and referral programs. This study will provide valuable information about one distress screening and referral program and whether it can be helpful for a large and diverse group of cancer patients that includes both English- and Spanish-speaking patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 22, 2025
CompletedFirst Submitted
Initial submission to the registry
August 5, 2025
CompletedFirst Posted
Study publicly available on registry
August 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 22, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 22, 2026
October 16, 2025
October 1, 2025
1 year
August 5, 2025
October 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participant referral rate to mental health services
To track outcomes of a pilot distress screening and referral program at Jamaica Hospital Medical Center with English- and Spanish-speaking cancer patients (n=50), by assessing referral rate to mental health services.
3 months
Study Arms (1)
Participants with a New Solid Tumor Diagnosis
EXPERIMENTALParticipants will have a new solid tumor cancer diagnosis.
Interventions
A tool used to determine on a number scale the amount of distress for the past week
Eligibility Criteria
You may qualify if:
- New solid tumor cancer diagnosis (per EMR)
- Treated or will be treated at Jamaica Hospital Medical Center (per EMR)
- Has a NCCN DT score of 0 through 10 (per EMR)
- Age ≥ 18 years (per EMR or self-report)
- English- or Spanish preferred language for healthcare (per self-report)
- Able to provide consent (per completion of consent)
You may not qualify if:
- In the provider or investigative teams' judgement, cognitively not intact to participate in the study (per EMR or investigative team)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065, United States
Medisys Health Network (Data Collection Only)
Richmond Hill, New York, 11418, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Devika Jutagir, PhD
Memorial Sloan Kettering Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2025
First Posted
August 12, 2025
Study Start
July 22, 2025
Primary Completion (Estimated)
July 22, 2026
Study Completion (Estimated)
July 22, 2026
Last Updated
October 16, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.